STENOCARE is shortlisted for European Cannabis Company of the Year
STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S (“Stenocare”) is honored to be recognized as one of the leading European Cannabis Companies in the industry annual award.
Stenocare has been an active participant in the European medical cannabis industry since it was founded in 2017. The company has entered six different countries with prescription-based medical cannabis products and has been an active participant in developing these markets.
Now, Stenocare has been nominated and shortlisted in the annual industry awards as one of the best European Cannabis Companies of the Year. The European industry has hundreds of companies across the entire medical cannabis value chain, and a total of seven companies have been shortlisted for the prestigious award “European Cannabis Company of the Year”.
The Business of Cannabis Awards are dedicated to honouring excellence in various facets of the cannabis sector, showcasing innovations, leadership, and growth within this dynamic industry. This year's event promises to be a remarkable gathering of industry leaders, innovators, and influencers.
Comment from CEO, Thomas Skovlund Schnegelsberg: “We are both honoured and humbled by the recognition of being one of the best medical cannabis companies in Europe. We have a strategy of becoming a leading European brand within medical cannabis, and being shortlisted with a group of highly professional peers shows that we are on the right path toward that ambition.”
The winner of “European Cannabis Company of the Year” will be announced during the annual industry conference “Cannabis Europa” in London on June 25.
For additional information regarding STENOCARE, please contact:
Thomas Skovlund Schnegelsberg, CEO Phone: +45 31770060 E-mail: presse@stenocare.com
About STENOCARE A/S
Stenocare was founded in 2017 with the purpose of supplying prescription-based medical cannabis to patients in Denmark and internationally. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. Stenocare sources its products from a number of carefully selected international high-quality suppliers and operates a unique, indoor state-of-the-art cultivation facility in Denmark, that has multiple levels of redundancy to safeguard quality and uniformity in a pesticide free production process www.stenocare.com